|Assessment Process Complete
|Indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended
|Full submission received from Applicant
|NCPE assessment completed
|NCPE assessment outcome
|Reimbursement Not Recommended at the Submitted Price.
The HSE has approved reimbursement following confidential price negotiations June 2017.